Incidental Mutation 'IGL02642:Hpd'
ID 301774
Institutional Source Australian Phenomics Network (link to record)
Gene Symbol Hpd
Ensembl Gene ENSMUSG00000029445
Gene Name 4-hydroxyphenylpyruvic acid dioxygenase
Synonyms Fla, Hppd, Flp, Laf
Accession Numbers
Essential gene? Probably non essential (E-score: 0.101) question?
Stock # IGL02642
Quality Score
Status
Chromosome 5
Chromosomal Location 123309870-123320786 bp(-) (GRCm39)
Type of Mutation missense
DNA Base Change (assembly) C to T at 123319503 bp (GRCm39)
Zygosity Heterozygous
Amino Acid Change Valine to Isoleucine at position 22 (V22I)
Ref Sequence ENSEMBL: ENSMUSP00000121922 (fasta)
Gene Model predicted gene model for transcript(s): [ENSMUST00000031398] [ENSMUST00000154713]
AlphaFold P49429
Predicted Effect possibly damaging
Transcript: ENSMUST00000031398
AA Change: V61I

PolyPhen 2 Score 0.629 (Sensitivity: 0.87; Specificity: 0.91)
SMART Domains Protein: ENSMUSP00000031398
Gene: ENSMUSG00000029445
AA Change: V61I

DomainStartEndE-ValueType
Pfam:Glyoxalase 18 138 5.6e-10 PFAM
Pfam:Glyoxalase_4 20 134 7.7e-10 PFAM
Pfam:Glyoxalase_2 24 147 4.5e-9 PFAM
Pfam:Glyoxalase 180 335 2.1e-21 PFAM
Predicted Effect noncoding transcript
Transcript: ENSMUST00000124110
Predicted Effect possibly damaging
Transcript: ENSMUST00000154713
AA Change: V22I

PolyPhen 2 Score 0.863 (Sensitivity: 0.83; Specificity: 0.93)
SMART Domains Protein: ENSMUSP00000121922
Gene: ENSMUSG00000029445
AA Change: V22I

DomainStartEndE-ValueType
SCOP:d1cjxa1 1 122 3e-13 SMART
PDB:1SQI|B 1 159 1e-113 PDB
Predicted Effect noncoding transcript
Transcript: ENSMUST00000156539
Predicted Effect noncoding transcript
Transcript: ENSMUST00000181022
Predicted Effect noncoding transcript
Transcript: ENSMUST00000199260
Coding Region Coverage
Validation Efficiency
MGI Phenotype FUNCTION: [Summary is not available for the mouse gene. This summary is for the human ortholog.] The protein encoded by this gene is an enzyme in the catabolic pathway of tyrosine. The encoded protein catalyzes the conversion of 4-hydroxyphenylpyruvate to homogentisate. Defects in this gene are a cause of tyrosinemia type 3 (TYRO3) and hawkinsinuria (HAWK). Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jan 2010]
PHENOTYPE: CBA, C3H, DBA/2, SM and AKR have the F.1 form of this soluble liver antigen; A/J, A2G, BALB/c and C57BL/10 the F.2 form. F.2 antigen induces precipitating antibodies in F.1 but not F.2 strains and vice versa. F antigen immune response requires H2 Kk or Ak alleles. [provided by MGI curators]
Allele List at MGI
Other mutations in this stock
Total: 59 list
GeneRefVarChr/LocMutationPredicted EffectZygosity
Acadm T C 3: 153,644,720 (GRCm39) D68G probably damaging Het
Amer3 A G 1: 34,625,761 (GRCm39) probably benign Het
Ankrd11 A G 8: 123,617,390 (GRCm39) L2133P probably damaging Het
Bcdin3d G T 15: 99,368,673 (GRCm39) H175Q probably damaging Het
Brd8 C A 18: 34,741,117 (GRCm39) probably benign Het
C1rl C A 6: 124,470,806 (GRCm39) T38N possibly damaging Het
Cd160 T C 3: 96,707,927 (GRCm39) T140A probably benign Het
Cdk16 T G X: 20,563,167 (GRCm39) D381E probably benign Het
Cpq G A 15: 33,381,546 (GRCm39) G303D probably damaging Het
Dmp1 T C 5: 104,359,536 (GRCm39) S71P probably damaging Het
Enc1 A C 13: 97,382,042 (GRCm39) D184A possibly damaging Het
Enkur T C 2: 21,199,198 (GRCm39) D112G probably benign Het
Esrra A T 19: 6,890,218 (GRCm39) V59E possibly damaging Het
F830016B08Rik A G 18: 60,433,058 (GRCm39) N47S probably benign Het
Fads1 T A 19: 10,163,785 (GRCm39) V189D probably damaging Het
Fam167a T A 14: 63,689,721 (GRCm39) I6N probably damaging Het
Fam98b A G 2: 117,090,793 (GRCm39) T164A probably benign Het
Fhip2a A G 19: 57,373,782 (GRCm39) N681D possibly damaging Het
Fryl T A 5: 73,252,809 (GRCm39) I953L probably benign Het
Gm10610 T A 7: 83,198,813 (GRCm39) noncoding transcript Het
Grik5 G T 7: 24,758,408 (GRCm39) N338K possibly damaging Het
Gstt2 A G 10: 75,668,652 (GRCm39) I72T probably benign Het
Gusb T C 5: 130,029,376 (GRCm39) probably null Het
Hccs A G X: 168,098,588 (GRCm39) probably benign Het
Hoxb4 A G 11: 96,211,050 (GRCm39) K217E probably damaging Het
Ighv1-47 A G 12: 114,954,844 (GRCm39) Y79H probably damaging Het
Il7r C A 15: 9,513,133 (GRCm39) probably benign Het
Lama1 A T 17: 68,119,361 (GRCm39) M2613L probably benign Het
Lama2 G A 10: 27,343,269 (GRCm39) H68Y probably damaging Het
Lce1c C A 3: 92,587,845 (GRCm39) probably benign Het
Lmx1a G T 1: 167,672,192 (GRCm39) probably benign Het
Lrfn1 T C 7: 28,158,113 (GRCm39) probably benign Het
Lrriq1 T A 10: 103,057,322 (GRCm39) probably null Het
Mri1 A T 8: 84,983,702 (GRCm39) L63Q probably damaging Het
Mrps11 G T 7: 78,438,522 (GRCm39) probably null Het
Mtif2 C A 11: 29,494,395 (GRCm39) Q666K probably benign Het
Mtr A T 13: 12,210,118 (GRCm39) probably benign Het
Mug1 A G 6: 121,859,544 (GRCm39) N1181S probably benign Het
Myom1 A T 17: 71,408,093 (GRCm39) E1209V possibly damaging Het
Nhsl1 A G 10: 18,284,138 (GRCm39) I26M possibly damaging Het
Nlrp1a T A 11: 71,014,358 (GRCm39) K297N probably benign Het
Obox5 T C 7: 15,491,972 (GRCm39) V129A probably benign Het
Pex16 C T 2: 92,206,981 (GRCm39) A53V probably damaging Het
Pfpl T C 19: 12,407,107 (GRCm39) F453L probably damaging Het
Pip5k1b G T 19: 24,323,731 (GRCm39) H406N probably benign Het
Pip5k1c C A 10: 81,153,155 (GRCm39) probably null Het
Plcxd3 T C 15: 4,546,122 (GRCm39) F42S possibly damaging Het
Pnpla7 T C 2: 24,940,288 (GRCm39) F1056L probably benign Het
Rapgef1 T C 2: 29,590,872 (GRCm39) probably benign Het
Rdh11 G A 12: 79,232,110 (GRCm39) probably benign Het
Serac1 A G 17: 6,096,021 (GRCm39) F576S possibly damaging Het
Slc45a4 A T 15: 73,458,664 (GRCm39) M295K probably benign Het
Taf1c T C 8: 120,325,796 (GRCm39) T689A probably benign Het
Timm10b G T 7: 105,317,645 (GRCm39) probably benign Het
Tle5 A T 10: 81,397,126 (GRCm39) Q34L possibly damaging Het
Tnc A T 4: 63,883,816 (GRCm39) probably benign Het
Toporsl T C 4: 52,611,114 (GRCm39) W336R probably benign Het
Usp54 C A 14: 20,615,140 (GRCm39) probably benign Het
Vmn1r233 T C 17: 21,214,291 (GRCm39) R220G probably damaging Het
Other mutations in Hpd
AlleleSourceChrCoordTypePredicted EffectPPH Score
IGL02483:Hpd APN 5 123,320,641 (GRCm39) splice site probably null
IGL02510:Hpd APN 5 123,319,973 (GRCm39) missense possibly damaging 0.95
IGL02574:Hpd APN 5 123,317,420 (GRCm39) splice site probably benign
IGL03374:Hpd APN 5 123,310,108 (GRCm39) missense probably damaging 1.00
Intermediary UTSW 5 123,315,587 (GRCm39) splice site probably null
metabolism UTSW 5 123,312,443 (GRCm39) missense probably benign
pyruvian UTSW 5 123,316,255 (GRCm39) nonsense probably null
R0079:Hpd UTSW 5 123,319,544 (GRCm39) missense probably damaging 1.00
R1022:Hpd UTSW 5 123,312,532 (GRCm39) missense possibly damaging 0.94
R1024:Hpd UTSW 5 123,312,532 (GRCm39) missense possibly damaging 0.94
R1165:Hpd UTSW 5 123,314,153 (GRCm39) critical splice donor site probably null
R2414:Hpd UTSW 5 123,315,587 (GRCm39) splice site probably null
R6572:Hpd UTSW 5 123,318,739 (GRCm39) missense probably benign 0.22
R6604:Hpd UTSW 5 123,318,964 (GRCm39) splice site probably null
R6616:Hpd UTSW 5 123,310,123 (GRCm39) missense probably damaging 1.00
R7539:Hpd UTSW 5 123,316,255 (GRCm39) nonsense probably null
R7952:Hpd UTSW 5 123,316,327 (GRCm39) missense possibly damaging 0.91
R8023:Hpd UTSW 5 123,314,297 (GRCm39) missense probably damaging 1.00
R8086:Hpd UTSW 5 123,314,252 (GRCm39) missense probably benign 0.20
R8134:Hpd UTSW 5 123,312,443 (GRCm39) missense probably benign
R9029:Hpd UTSW 5 123,313,973 (GRCm39) missense probably damaging 1.00
R9390:Hpd UTSW 5 123,318,794 (GRCm39) critical splice acceptor site probably null
R9483:Hpd UTSW 5 123,312,535 (GRCm39) missense probably damaging 1.00
R9532:Hpd UTSW 5 123,312,532 (GRCm39) missense possibly damaging 0.94
R9641:Hpd UTSW 5 123,310,052 (GRCm39) missense probably benign
R9664:Hpd UTSW 5 123,318,948 (GRCm39) critical splice donor site probably null
X0023:Hpd UTSW 5 123,312,502 (GRCm39) missense probably damaging 1.00
Z1176:Hpd UTSW 5 123,319,538 (GRCm39) missense probably damaging 1.00
Posted On 2015-04-16